Influences of Donor and Recipient Gene Polymorphisms on Tacrolimus Dosing and Pharmacokinetics in Asian Liver Transplant Patients

ISSN Print: 2163-9485
ISSN Online: 2163-9493
www.scirp.net/journal/ojots
E-mail: [email protected]

Citations

"Influences of Donor and Recipient Gene Polymorphisms on Tacrolimus Dosing and Pharmacokinetics in Asian Liver Transplant Patients"
written by Mei-Ling Yee, Hui-Hui Tan, Wan-Jin Sia, Wai-Ping Yau,
published by Open Journal of Organ Transplant Surgery, Vol.3 No.3, 2013

has been cited by the following article(s):

[1]	Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A‐status in liver transplant recipients
	2021

[2]	Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases
	2019

[3]	Combination of Ketoconazole and Tacrolimus Increases the Risk of Kidney Transplant Rejection in African Americans
	2018

[4]	Effect of CYP 3A5* 1 expression on Tacrolimus required dose after liver transplantation: A systematic review and meta‐analysis
	Clinical transplantation, 2018

[5]	Effect of ABCB1 (3435C> T) and CYP3A5 (6986A> G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients
	Egyptian Journal of Medical Human Genetics, 2016

[6]	WJCO
	2014

[7]	他克莫司和卡泊三醇软膏治疗四肢斑块状银屑病的疗效和安全性分析
	现代生物医学进展, 2014

[8]	Long-term outcome of ketoconazole and tacrolimus co-administration in kidney transplant patients
	World journal of nephrology, 2014

[9]	WJN
	2014

[1]	The Impact of ABCB1 SNPs on Tacrolimus Pharmacokinetics in Liver or Kidney Transplant Recipients: A Meta-analysis Current Pharmaceutical Design, 2023 DOI:10.2174/0113816128259239231009112019

[2]	Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A‐status in liver transplant recipients British Journal of Clinical Pharmacology, 2021 DOI:10.1111/bcp.14566

[3]	Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases Pharmacological Reports, 2019 DOI:10.1016/j.pharep.2019.01.006

[4]	Effect of CYP3A51 expression on tacrolimus required dose after liver transplantation: A systematic review and meta-analysis Clinical Transplantation*, 2018 DOI:10.1111/ctr.13306

[5]	Effect of ABCB1 (3435C>T) and CYP3A5 (6986A>G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients Egyptian Journal of Medical Human Genetics, 2017 DOI:10.1016/j.ejmhg.2016.10.005